Literature DB >> 4399183

Modification of graft-versus-host disease by neuraminidase treatment of donor cells. Decreased tolerogenicity of neuraminidase-treated cells.

H M Im, R L Simmons.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4399183     DOI： 10.1097/00007890-197112000-00010

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  4 in total

1.  Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.

Authors:  R L Simmons; A Rios
Journal:  Ann Surg       Date:  1972-08       Impact factor: 12.969

2.  Vibrio Cholerae neuraminidase susceptible N-acetyl neuraminic acid (sialic acid) levels in human leukaemia.

Authors:  A H Ryan; J J Fennelly
Journal:  Ir J Med Sci       Date:  1978-09       Impact factor: 1.568

3.  The haemopoietic and immunogenic capacities of living hybrid bone marrow cells tested in tumour allograft rejection.

Authors:  J A Kerckhaert; F M Hofhuis; J M Willers
Journal:  Immunology       Date:  1975-04       Impact factor: 7.397

4.  Neuraminidase and tumor immunotherapy.

Authors:  H H Sedlacek; F R Seiler; H G Schwick
Journal:  Klin Wochenschr       Date:  1977-03-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.